EVAH Corp.

About EVAH Corp.

EVAH Corp is a Canadian biotechnology company based in Quebec, focused on developing animal health technologies. Their mission is to find better ways to feed the planet, address consumer needs for non-antibiotic protein, and increase the sustainability of food through innovation.

Products & Services

Animal Health Technologies:Developing technologies for sustainable food production, including production animal vaccines and alternatives to antibiotics.

Innovation in Animal Health:Focused on innovative solutions for enhancing food animal health.

Specialties

Animal Health Technologies Production Animal Vaccines Alternatives to Antibiotics Sustainable Food Production

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Government Funding (Repayable Contributions) T: - FT: Government Funding (Repayable Contributions)	A: 800000 MR: - FA: $800,000 FAN: 800000	D: 2024-10-18 FD: 2024-10-18	1 investors

Government Funding (Repayable Contributions) Latest

2024-10-18

$800K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michel Fortin

President & Chief Executive Officer

LinkedIn (Pro only)

E

Erika Tremblay-Gagnon

CFO

LinkedIn (Pro only)

F

Frédéric Beaulac

DVM

P

Pierre Falardeau

Chief Innovation Officer

M

Martin Leblanc

Co-founder and CEO

B

Brian M. Levitt

Non-executive Independent Board Chair of TD Bank Group

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

EVAH Corp. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised